ScholarIQanswers from OpenAlex

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

PaperCitations, authors & open-access status

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer have?

ScholarIQcitation count

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer has 394 citations in the OpenAlex counts ScholarIQ stores.

When was Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer published?

ScholarIQyear

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer has 2021 year in the ScholarIQ index.

What is the open-access status of Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer?

ScholarIQoa status

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer has green oa status in the ScholarIQ index.

What is the DOI of Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer?

ScholarIQdoi

The DOI for Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer is on the source record.

What is the PMID of Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer?

ScholarIQpmid

The PMID for Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer is on the source record.

What is the OpenAlex record for Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer?

ScholarIQopenalex

The OpenAlex for Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial